-
Orbit Genomics is recognized by MedTech Innovator as one of the 50 best-in-class startups in the medtech industry.
-
CSO, Skip Garner, in the News
Researchers in Blacksburg Develop Lung Cancer Risk Genetic Test
-
Microsatellite Genotyping in Lung Cancer
Orbit Genomics Co-Founder and CSO, Dr. Harold “Skip” Garner, is the senior author on a paper appearing in Oncogene (31 July 2017) entitled “High-depth, high-accuracy microsatellite genotyping enables precision lung cancer risk classification” and can be viewed at http://rdcu.be/uCMU. Early detection and screening for lung cancer can help overcome the high incidence and poor survival rates of this deadly disease.
